• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症生存率恶化的原因。

Explanations for worsening cancer survival.

机构信息

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

出版信息

Nat Rev Clin Oncol. 2010 Jan;7(1):60-3. doi: 10.1038/nrclinonc.2009.184.

DOI:10.1038/nrclinonc.2009.184
PMID:20029445
Abstract

If cancer survival is reported to be worsening over time or inferior compared to other countries, politicians and health-care workers may get blamed because suboptimal care is presumed to be the cause. Yet, a variety of reasons exist for cancer survival statistics to change for the worse, of which deterioration of care is only one. Another explanation is that the improved diagnosis of premalignant lesions causes survival statistics to reflect only the most aggressive cancers-those with the poorest prognosis. In addition, deleterious changes in the distribution of prognostic factors and in the distribution of sociodemographic characteristics may negatively affect survival proportions. In this article, we identify the pitfalls that might be encountered in comparisons of published, population-based survival data from different time periods or populations.

摘要

如果癌症的存活率报告显示随着时间的推移而恶化,或者比其他国家差,政治家和医疗保健工作者可能会受到指责,因为人们认为治疗效果不佳是造成这种情况的原因。然而,癌症存活率数据恶化的原因有很多,治疗效果不佳只是其中之一。另一个解释是,癌前病变的诊断水平提高,导致生存统计数据仅反映出最具侵袭性的癌症,即预后最差的癌症。此外,预后因素分布和社会人口特征分布的有害变化可能会对生存率产生负面影响。在本文中,我们确定了在比较不同时期或人群的已发表的基于人群的生存数据时可能遇到的陷阱。

相似文献

1
Explanations for worsening cancer survival.癌症生存率恶化的原因。
Nat Rev Clin Oncol. 2010 Jan;7(1):60-3. doi: 10.1038/nrclinonc.2009.184.
2
Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix.北欧国家 1964-2003 年间诊断的癌症患者总体生存趋势:病例组合的重要性。
Acta Oncol. 2010 Jun;49(5):713-24. doi: 10.3109/0284186X.2010.484426.
3
US cancer mortality continues to fall.美国癌症死亡率持续下降。
BMJ. 2015 Jan 5;350:h21. doi: 10.1136/bmj.h21.
4
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
5
[Model program for screening oral cancers in the Roma population].[罗姆人口口腔癌筛查示范项目]
Magy Onkol. 2007;51(2):95-101. Epub 2007 Jul 29.
6
Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.印度孟买(旧称: Bombay)预后不良癌症的人群生存率。
Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):175-82.
7
Association of insurance with cancer care utilization and outcomes.保险与癌症医疗利用及结局的关联。
CA Cancer J Clin. 2008 Jan-Feb;58(1):9-31. doi: 10.3322/CA.2007.0011. Epub 2007 Dec 20.
8
Cancer survival in California Hispanic farmworkers, 1988-2001.1988 - 2001年加利福尼亚州西班牙裔农场工人的癌症生存率
J Rural Health. 2007 Winter;23(1):33-41. doi: 10.1111/j.1748-0361.2006.00065.x.
9
[Administrative and medicosocial activity of the centers for the fight against cancer and advanced consultations in 1966 and 1967].
Bull Inst Natl Sante Rech Med. 1969 Mar-Apr;24(2):237-66.
10
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.

引用本文的文献

1
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.4594 例日本黑色素瘤患者的临床和组织病理学特征及生存分析。
Cancer Med. 2019 May;8(5):2146-2156. doi: 10.1002/cam4.2110. Epub 2019 Apr 1.
2
A further caveat in interpreting cancer survival.解读癌症生存率时的另一个注意事项。
Nat Rev Clin Oncol. 2010 Apr;7(4):184-c1; author reply 184-c2. doi: 10.1038/nrclinonc.2009.184-c1.

本文引用的文献

1
How to interpret the relative survival ratios of cancer patients.如何解读癌症患者的相对生存率。
Eur J Cancer. 2008 Nov;44(17):2661-7. doi: 10.1016/j.ejca.2008.08.016. Epub 2008 Sep 24.
2
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.欧洲癌症的近期趋势:自20世纪90年代以来17种癌症部位发病率、生存率和死亡率的综合研究方法
Eur J Cancer. 2008 Jul;44(10):1345-89. doi: 10.1016/j.ejca.2007.12.015. Epub 2008 Feb 14.
3
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
欧洲近期癌症生存率:基于EUROCARE-4数据的2000 - 2002年期间分析
Lancet Oncol. 2007 Sep;8(9):784-96. doi: 10.1016/S1470-2045(07)70246-2.
4
Recent major progress in long-term cancer patient survival disclosed by modeled period analysis.通过模型化时期分析揭示的长期癌症患者生存的近期重大进展。
J Clin Oncol. 2007 Aug 1;25(22):3274-80. doi: 10.1200/JCO.2007.11.3431.
5
The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.对于T1期膀胱癌,膀胱内治疗的使用日益增加,与此同时,膀胱切除术后的生存率却在下降。
BJU Int. 2007 Jul;100(1):33-6. doi: 10.1111/j.1464-410X.2007.06912.x.
6
Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.解读癌症生存率的国际比较:不完全登记以及仅存在死亡证明病例对生存估计的影响。
Eur J Cancer. 2007 Mar;43(5):909-13. doi: 10.1016/j.ejca.2007.01.007. Epub 2007 Feb 14.
7
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
8
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.癌症合并糖尿病患者的治疗积极性较低且总生存率较差:一项基于大样本人群的分析。
Int J Cancer. 2007 May 1;120(9):1986-92. doi: 10.1002/ijc.22532.
9
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.美国的喉癌:人口统计学变化、治疗模式及生存率
Laryngoscope. 2006 Sep;116(9 Pt 2 Suppl 111):1-13. doi: 10.1097/01.mlg.0000236095.97947.26.
10
Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project.1978 - 1997年欧洲儿童及青少年白血病发病率与生存率。自动儿童癌症信息系统项目报告。
Eur J Cancer. 2006 Sep;42(13):2019-36. doi: 10.1016/j.ejca.2006.06.005.